We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  For example, here is how to disable FireFox ad content blocking while on Silicon Investor.
Biotech / Medical : GORX - GeoPharma, Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: jmhollen8/3/2005 5:23:30 PM
   of 7
GeoPharma Announces First Quarterly Earnings Conference Call

LARGO, Fla., July 29, 2005 /PRNewswire-FirstCall via COMTEX/ -- GeoPharma, Inc. (Nasdaq: GORX), will hold its quarterly conference call to discuss June 30, 2005 quarterly results on Wednesday, August 3, 2005, at 11:00 a.m. (ET). Participants can call in on Wednesday, August 3, 2005 at 10:55 a.m. at 1-800-265-0241, passcode 33189768.

The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at , Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents ( ), a password-protected event management site.

About GeoPharma, Inc.

GeoPharma, Inc. is a rapidly growing pharmaceutical company specializing in the manufacturing and distribution of over-the-counter, nutritional, generic drug and functional food products. The company's growth strategy is to capitalize on its manufacturing expertise to develop high margin generic or novel drugs for niche human and animal health markets with high barriers to entry. GeoPharma's competitive advantage lies in its ability to circumvent or overcome the challenges in these markets. For more about GeoPharma, Inc., go to our websites at , and .

SOURCE GeoPharma, Inc.
Carol Dore-Falcone, GeoPharma, Inc., +1-727-544-8866
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext